PIRFENOID 200 : "PIRFENOID 200: Advanced Care for Pulmonary Fibrosis"

PIRFENOID 200

Pirfenidone (200mg)

PIRFENOID 200 combination of Pirfenidone (200mg), often abbreviated as PIRFENOID 200, is a medication used in the treatment of idiopathic pulmonary fibrosis (IPF). This article provides a detailed exploration of Pirfenidone (200mg), its uses, benefits, and considerations.

Understanding Pirfenidone (200mg) Pirfenidone is an antifibrotic agent that works by reducing fibrosis and inflammation in the lungs, slowing the progression of IPF. PIRFENOID 200 tablets contain 200mg of pirfenidone, offering targeted therapy for individuals with this chronic and progressive lung disease.

Uses of Pirfenidone (200mg)

1. Idiopathic Pulmonary Fibrosis (IPF): PIRFENOID 200 is indicated for the treatment of IPF, a condition characterized by the scarring of lung tissue, leading to decreased lung function and difficulty breathing.
2. Slowing Disease Progression: Pirfenidone helps slow the decline in lung function and reduces the risk of disease progression in individuals with IPF, improving quality of life and survival rates.

Benefits of PIRFENOID 200

• Disease Modification: Pirfenidone (200mg) is one of the few medications shown to modify the course of IPF, offering hope for individuals with this challenging condition.
• Improved Lung Function: Treatment with PIRFENOID 200 has been associated with slower decline in forced vital capacity (FVC) and improved exercise tolerance in patients with IPF.
• Tolerability: While some individuals may experience mild side effects such as nausea or rash, Pirfenidone (200mg) is generally well-tolerated, allowing for long-term use.

Precautions and Considerations

• Liver Function Monitoring: Regular monitoring of liver function tests is recommended during treatment with Pirfenidone (200mg) to detect any potential hepatotoxicity.
• GI Side Effects: Some users may experience gastrointestinal side effects such as nausea, vomiting, or diarrhea, which can usually be managed with supportive measures or dose adjustments.
• Pregnancy and Breastfeeding: PIRFENOID 200 should not be used during pregnancy or breastfeeding due to potential risks to the fetus or infant.

Conclusion:

Pirfenidone (200mg) tablets offer a targeted therapeutic approach for individuals with idiopathic pulmonary fibrosis, slowing disease progression and improving lung function. With its demonstrated efficacy, tolerability, and potential to modify the course of IPF, PIRFENOID 200 provides hope and improved quality of life for patients facing this challenging condition. However, it's essential to follow prescribing guidelines and heed precautions to ensure safe and optimal use.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

For further information: 

EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

CALL/WHATSAPP: 7877551268, 7849827488

BUY NOW